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Abstract
Despite progresses in identifying the cellular mechanisms at the basis of the differentia-
tion of hematopoietic stem/progenitor cells, little is known about the regulatory circuitry at
the basis of lineage commitment of hematopoietic multipotent progenitors. To address
this issue, we propose a computational approach to give further insights in the compre-
hension of this genetic mechanism. Differently from T lymphopoiesis, however, there is at
present no mathematical model describing lineage restriction of multipotent progenitors to
early B-cell precursors. Here, we provide a first model—constructed on the basis of cur-
rent experimental evidence from literature and of publicly available microarray datasets—
of the genetic regulatory network driving the cellular fate determination at the stage of lym-
phoid lineage commitment, with particular regard to the multipotent-B-cell progenitor tran-
sition. By applying multistability analysis methods, we are able to assess the capability of
the model to capture the experimentally observed switch-like commitment behavior.
These methods allow us to confirm the central role of zinc finger protein 521 (ZNF521) in
this process, that we had previously reported, and to identify a novel putative functional
interaction for ZNF521, which is essential to realize such characteristic behavior. More-
over, using the devised model, we are able to rigorously analyze the mechanisms under-
pinning irreversibility of the physiological commitment step and to devise a possible
reprogramming strategy, based on the combined modification of the expression of
ZNF521 and EBF1.
Introduction
The differentiation of hematopoietic cell is governed by several control mechanisms, at differ-
ent levels and in a highly hierarchical manner, from hematopoietic stem cells (HSCs) to
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lymphoid multipotent progenitors (LMPPs) that can further develop toward lineage restricted
progenitors (LRPs). In these mechanisms, some transcription factors play a key role in the
determination of the hematopoietic lineage. Observing these mechanisms from a systemic
viewpoint, the following questions arise: (i)Which are the upstream regulators of the transcrip-
tion factors that determine the lineage of differentiation of a certain progenitor or immature
cell? (ii)Which are the transcription factors that constitute a minimal set for the activation of
the differentiation process in hematopoietic cells? (iii) Is the differentiation an irreversible
event (i.e., once the cell is committed to a certain path, it cannot change), or is it possible to
observe phenomena of plasticity? While these and other issues, related to the regulation of
hematopoietic development and differentiation, clearly require extensive and time-consuming
experimental investigations, the exploitation of mathematical models and associated theoreti-
cal analysis tools can significantly boost the comprehension of the lineage specification
mechanisms.
The control of HSCs differentiation towards mature hematopoietic cells is a sequential pro-
cess, consisting of several lineage-determining steps. Each step requires a decision mechanism,
which is assumed to be highly regulated by a combination of transcription factors, epigenetic
events, and extrinsic regulator cytokines [1]. Prior to commitment, it has been observed that
many genes involved in HSCs differentiation are expressed at intermediate or basal levels [2,
3]. This “transcriptional priming” at the stage of early progenitors may induce the rapid
deployment of transcription factors to implement the subsequent commitment mechanisms.
In hematopoiesis there exist several lineage branch points with identified key transcription fac-
tors and external signals [4–6]. For instance, a particularly well studied subnetwork is the one
involving the genes PU.1 and GATA-1, which underlies the erythroid-myeloid lineage-determi-
nation step and has been proved to exhibit both a commitment switch and priming features
[7–12]. In many cases, switch-like gene circuits have evolved to realize a sort of cellular built-in
memory, which can lead to phenotypic diversity [13].
Several models have been proposed to describe a late stage of B-lymphocytes differentiation
into terminal B-cells: sustained exposure to CD40L has been suggested to direct germinal cen-
ter B-cells toward the memory B-cell compartment [14]; a bistable switch arising from the cou-
pled double-negative feedback loops involving BCL-6, BLIMP-1 and PAX5 forms the basis of
the B-cell to plasma cell differentiation program and its disruption by dioxin [15]; in [16], the
authors developed a kinetic model to quantitatively characterize B-cell exit from the germinal
center phase and terminal differentiation into plasma and memory B-cells.
Differently from those related to the terminal phases, the regulatory mechanisms underlying
other lineage-determination steps are still poorly understood: for instance, to our knowledge,
no model of the early B-lymphopoiesis commitment switch has been devised so far. Thus, the
present work focuses on the analysis of this important mechanism. In particular, we first
develop a dynamical model in order to clearly identify a regulatory network of genes/transcrip-
tion factors involved in cellular fate determination of B-lymphoid lineage specification, based
on the experimental evidence reported in literature. A special emphasis is given to the role of
ZNF521, a key regulator and crucial antagonist of some genes involved in the B-lymphoid
commitment regulatory network, as recently proved in experimental studies [17, 18]. Morrone
and coworkers have suggested that ZNF521, in concert with other transcription factors, influ-
ences self-renewal and differentiation of primitive progenitors in hematopoiesis.
Exploiting the proposed mathematical model, we have studied the gene network regulating
B-lymphoid commitment switch; in particular, we have investigated the role of several novel
putative interactions by comparing the behavior of the alternative models against the available
experimental data. Bifurcation analysis and numerical simulations have shown that the cur-
rently known interactions are not sufficient to generate the bistable behavior that distinguishes
Computational Modeling of B-Lymphocyte Lineage Commitment
PLOS ONE | DOI:10.1371/journal.pone.0132208 July 13, 2015 2 / 23
biological switches; moreover, the analysis of the extended models quantitatively proves that a
novel interaction, that is the inhibition of ZNF521 expression by the B-cell lineage specific acti-
vator protein PAX5 [19], is required for the model to exhibit the commitment switch. Finally,
the devised mathematical model is exploited to investigate possible strategies for reprogram-
ming B-lymphoid LRPs into LMPPs.
Results
B-cell lineage commitment model and the role of ZNF521
Robust cell fate commitment is based on the activation and inhibition of the expression of cer-
tain genes. The two cytokine receptors, FLT3 and IL-7R, and the seven transcription factors
PU.1, IKAROS, GFI1, E2A, EBF1, PAX5 and ZNF521 are critical for the development of B-cell
precursors. These factors form a gene regulatory network which activates during LMPPs com-
mitment towards B-lymphocytes development. We have assembled the functional interaction
network, shown in Fig 1, by manually mining the information from the literature, as reported
in S1 Text.
From a dynamical system perspective, this biological network implements a switch-like func-
tion and, therefore, is expected to exhibit a bistable behavior, i.e., it can robustly operate in two
distinct conditions. To enable the application of the analysis tools for bistability, we have comple-
mented the qualitative description provided by the network in Fig 1 with kinetic rules associated
to each interaction, thus devising the dynamical model Eqs (1a)–(1j). The model implicitly
assumes that the activity levels of transcription factors and cytokine receptors are roughly pro-
portional to their mRNA levels. In order to analyze their effect on early B-lymphopoiesis lineage
commitment the model includes two environmental factors, TEBF1 and TZNF521, which promote
the transcriptional activity of EBF1 and ZNF521, respectively. Modulating the effect of these
exogenous inputs, we can induce the switch between the two stable operative conditions, analyz-
ing the effect of EBF1 and ZNF521 on a continuous range of expression levels.
Fig 1. The key TF interactions in the B-lymphopoiesis circuit. The B-cell lineage is assumed to be
determined by the antagonism between ZNF521 and the specification of the B-lymphoid lineage driven by
E2A, EBF1 and PAX5. The interaction framework emerge out of literature. It is also supported by some
assumptions from the phenomenological observation that can lead to cellular switching. In order to gain this
particular behavior, considering well-known transcriptional motifs, we assumed a putative direct inhibition of
ZNF521 through the regulator PAX5, (dashed line). Arrows represent gene activation, blunt arrows gene
repression. TEBF1 and TZNF521, indicate environmental factors, which promote the transcriptional activity of
EBF1 and ZNF521, respectively.
doi:10.1371/journal.pone.0132208.g001
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The dynamics of the system cannot be determined without first specifying the parameter
values, fixing a point in the parameter space. The qualitative behavior of the commitment
switch in the B lymphopoiesis lineage is adapted, firstly, by a set of biochemical parameters for
the system in Eqs (1a)–(1j) that is reasonably consistent with the expression levels of microar-
ray gene profiles of the CD19+ CD127+ and CD19+ CD127− cells with B lineage cell subsets iso-
lated from pediatric marrow reported in [20, 21]. Since these earlier studies have been
conducted using the HG-U133 chip set (HG-U133A and HG-U133B), analysis has been con-
ducted over the 44,754 probe sets present in the two array types, which were then processed
using the Affymetrix platform Expression Console. The application uses the Robust Multichip
Analysis (RMA) in order to obtain the generation of experimental expression datasets. Further
statistical analysis is performed considering Affymetrix Transcriptome Analysis Console
(TAC) Software. Considering the different developmental lineages, we obtained a list of differ-
entially expressed genes in genome-wide comparison between multipotent stage and B lym-
phoid LRPs (pro-B), as reported in Fig 2 and S1 Fig.
Cell lineage determination in the state space
The state of our dynamical system, let us denote it by X, is defined by the expression levels of
the genes included in the regulatory network in Fig 1, that is X = (xIKAROS, xGFI1, xPU.1, . . ., xCD19),
where xIKAROS denotes the concentration of transcribed IKAROS mRNA. A point in the state
space is a stable equilibrium if every trajectory of the system starting in a small neighborhood
of that point remains close to it for an infinite time interval in the absence of exogenous inputs.
In order to implement a switch-like behavior, our system should exhibit two distinct equilib-
rium points: some genes will have high expression in one point and low in the other one, while
Fig 2. Gene level differential expression analysis. Every point in the scatter plots shows the expression of a gene in the two conditions CD34+/lin− vs. pro-
B. HG-U133AChip. Total number of genes evaluated: 22645, with 550 genes differentially expressed. CD34+/lin− vs. pro-B analysis shows that 167 genes
are up-regulated and 383 genes are down-regulated. HG-U133B Chip. Total number of genes evaluated: 22283 with 1080 genes differentially expressed
CD34+/lin− vs. pro-B analysis shows that 553 genes are up-regulated and 527 genes are down-regulated. According with the TAC default filter criteria, we
setted a fold change (linear) cut-off of ±2 (all that points having a fold-change less than 2 are shown in gray) and p-value < 0,05. Red: up in CD34+/lin− vs pro-
B; green: down in CD34+/lin− vs pro-B. Highlighted are shown the factors involved in the proposed model.
doi:10.1371/journal.pone.0132208.g002
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other genes may settle on an intermediate expression level in both conditions. These two equilib-
rium points of our model represent the multipotent progenitors and committed B precursors
conditions, and the model trajectories are attracted on one or the other depending on the initial
condition [22]. In general, all the state trajectories are limited by gene regulatory interactions
that represent effectively constraints in the dynamic evolution [23]. Indeed cellular development
creates only a small subset of states among all the possible states because a cell state does not
move entirely randomly. Obviously, individual genes do not alter their expression value inde-
pendently because of predetermined regulatory interactions. No gene regulatory interactions
entails free movement of states. In the proposed model, the admissible state trajectories are char-
acterized by implicit constraints: for instance, if the transcription factor ZNF521 inhibits the
expression of EBF1, then as ZNF521 increases its expression EBF1 is subjected to decrease.
A key circuit promotes irreversible bistable commitment switch between
LMPPs and lymphoid LRPs
In correspondence to the lymphoid multipotent stage, the two transcription factors IKAROS
and PU.1 initialize the lymphoid lineage commitment process, in particular activating the tran-
scription of FLT3, a receptor specifically expressed on the surface of LMPPs [24, 25]. PU.1, in
turn, is maintained at lower levels for the cell to persist in lymphoid line, avoiding the switching
to the myeloid one. GFI1 (activated by IKAROS) has been suggested to interact in a direct
manner with the promoter of SPI1 (the gene encoding PU.1 transcription), inhibiting its
expression; hence, IKAROS indirectly lowers PU.1 level [26]. Our analysis has highlighted that
the expression level of PU.1 cannot be simply nullified, but it must be finely regulated: indeed,
its presence is necessary for the regulation of the expression of IL-7R, which, in turn, is
required for the progression of the development from LMPPs to B-lymphoid lineage [27, 28].
The lymphoid LRPs commitment is guaranteed by the antagonism between ZNF521 and
the B-lymphoid lineage specific genes, like TCF3 (coding for E2A trascription factor), EBF1
and PAX5, see Fig 3. While most of the interactions between these factors have been unraveled
by means of biological experiments, evidence of regulation due to higher order multimeric
bindings is lacking; therefore, in our model we admit only heterodimeric pairwise. If this
Fig 3. Expression programs characterizing the commitment of LMPPs toward B-lymphoid LRPs. Each state is guaranteed by a distinctive expression
program of regulatory factors. In red (green), are depicted the factors up (down) regulated in each condition, LMPP and LRP, respectively. Values are taken
in arbitrary units from the experimental gene profiling datasets, reported in [20].
doi:10.1371/journal.pone.0132208.g003
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modeling assumption was removed, one could rather easily (and arbitrarily) tailor high-order
kinetics to obtain bistable dynamics. Our approach, instead, aims at the discovery of the key
interactions underpinning the lineage commitment switch and are, therefore, the most promis-
ing candidates to be investigated via wet-lab experiments.
The model built on the basis of the currently known experimentally validated interactions is
not able to reproduce the commitment switch behavior, i.e. it never achieves bistability, inde-
pendently of the assigned parameter values. This suggests that part of the regulatory network
still ought to be unveiled. Consequently, we have exploited the devised model to test additional
hypothetical interactions, chosen among the most likely on the basis of the literature and of the
knowledge of the domain expert.
The proposed in silicomodel, thus, provides an effective tool to rapidly sieve multiple
hypotheses on the topology of the interaction network. From the examination of different net-
work structures, only one interaction, namely the direct inhibition of the regulator PAX5 on
ZNF521, has resulted to be crucial to reproduce the dynamics of a bistable lineage commitment
switch. In fact, removing this inhibitory action of PAX5 on ZNF521 from the model, the system
does no longer exhibit a switching characteristic, even in the presence of other additional inter-
actions. For example, an alternative model featuring inhibition of ZNF521 through E2A cannot
yield bistable behavior, see Model B in S1 Text and S6 Fig. Recently, mouse studies on the tran-
scription factor Ikaros in early B-cell development have confirmed its role of regulator in lym-
phopoiesis, revealing also different activated or repressed target genes, among which the
murine equivalent for ZNF521 [29]. Based on these experimental evidences, a further alterna-
tive model characterized by a direct repression on ZNF521 through IKAROS has been consid-
ered, Model C in S1 Text and S6 Fig. However, numerical simulations suggest that repression
of IKAROS on ZNF521 is not able to induce bistable switching, see S6 Fig. Several other alter-
native interactions have been tested during the construction of the model, confirming that the
PAX5/ZNF521 interaction is essential to the realization of the switching mechanism.
The mechanism linking EBF1 expression level to B-lymphoid LRPs commitment has the
characteristics of an irreversible bistable switch, mediated by the feedback between
ZNF521-EBF1, PAX5, and the multipotency marker FLT3. The system behavior changes are
evaluated versus variations in control parameter regulating the transcriptional activity of EBF1
expression, TEBF1, by means of bifurcation analysis [30]. Externally modifying the value of
TEBF1, it is possible to replicate experimental variation in the expression of EBF1, essential for
the commitment of B-lymphocyte identity. Fig 4 shows a typical bistable characteristic, featur-
ing the presence of two stable steady-state branches delimited by two bifurcation points. All
the points included in the region of bistability admit either a low or high value in correspon-
dence to a single value of the bifurcation parameter. Note also that the bifurcation point located
on the negative semiaxis is inaccessible (expression levels cannot achieve negative values),
therefore the two branches of the bifurcation diagram are disconnected, which renders the
transition irreversible. In the bifurcation diagrams one branch corresponds to the multipotent
progenitor condition and the other to the B-lymphoid committed progenitor condition. Once
EBF1 level accumulates beyond the threshold, an irreversible transition occurs from multipo-
tent progenitor (LMPP cell, stable state I) to B-lymphoid LRP (pro-B cell, stable state II).
Analysis of the core feedback loops
In order to gain a deeper insight into the regulatory mechanisms that generate the lineage com-
mitment, in the following we explore the dynamics of the different subnetworks that compose
the core feedback loops. The expression and activity of EBF1 must be finely regulated in order to
maintain the commitment of B-lymphoid development and balancing B lymphopoiesis [31, 32].
Computational Modeling of B-Lymphocyte Lineage Commitment
PLOS ONE | DOI:10.1371/journal.pone.0132208 July 13, 2015 6 / 23
Among the inhibitors of EBF1, ZNF521 has been suggested to play a crucial role suppressing
EBF1 activity [17, 18, 33]. More recent experiments have also shown that Ebf1 cooperates in a
negative feedback loop to repress Zfp521 as differentiation proceeds [34]. Based on these experi-
mental evidences, we examine the simplest feedback module, comprising only EBF1 and
ZNF521, assuming heterodimeric bindings and positive autoregulations, S7 Fig (left panel). The
associated mathematical model takes the form reported in Eq (2). Considering the nominal
parameter values (S1 Table), the nullclines dZNF521/dt = 0 and dEBF1/dt = 0 intersect at a single
steady state (SS) corresponding to the LMPP point, S7 Fig (upper right panel). The bifurcation
diagrams in S7 Fig report the steady-state values of EBF1 and ZNF521 as function of the environ-
mental factor TEBF1. These diagrams show the existence of a single inaccessible turning point
(LP), thus system Eq (2) cannot provide a bistable switch. On the basis of this analysis, other
molecular interactions have to be included in the model in order to to obtain bistable dynamics.
The commitment of LMPPs to LRPs is essentially sustained by the three transcription fac-
tors E2A, EBF1 and PAX5 [35]. E2A acts upstream of EBF1 by modulating its expression and
hence, in concert with EBF1, activates the transcription of the PAX5 gene, leading to the rein-
forcement of the B-lymphoid commitment [36, 37]. Furthermore, EBF1 binds to and regulates
in a direct manner the expression of PAX5 [38] which, in turn, stimulates the EBF1 expression
through a positive feedback loop by binding to the proximal EBF1 promoter [39, 40]. Looking
at the dynamical behavior of the EBF1/E2A/PAX5 positive feedback loop, see S8 Fig (left
panel), it is possible to note that, although the cooperativity is increased by means of heterodi-
meric bindings between the TFs EBF1, E2A and PAX5, as described by Eq (3), the system can-
not yield the classical S-shaped bifurcation plot that is characteristic of a bistable switch.
Numerical continuation analysis, performed with respect to the environmental factor TEBF1,
shows the existence of a single steady-state, suggesting that this feedback module fosters persis-
tence in the committed state, S8 Fig (right panel).
Flt3-signaling cascade plays a very important role in B-cell development by priming early B-
cell progenitors in order to proceed toward the B-cell differentiation, promoting the expression
of IL-7 [41, 42]; indeed, mice lacking both FLT3- and IL-7R-derived signals fail to develop any
B-cells [43]. Furthermore, the presence of a negative feedback on FLT3 transcription by PAX5
has been documented [44]. Therefore, another important issue is whether the negative feed-
back loop EBF1/PAX5/FLT3/IL-7R, illustrated in S9 Fig (left panel), may contribute to
Fig 4. Irreversible and bistable switch in LMPPs commitment into B-lymphoid LRPs (pro-B cells). Steady state concentrations of FLT3, ZNF521,
PAX5 and CD19 as functions of an external signal TEBF1, which promotes B-cell development and represses ZNF521. All the points located on the negative
semiaxis, the shaded area, are inaccessible (expression levels of some species assume negative values). LP, Limit Point.
doi:10.1371/journal.pone.0132208.g004
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bistability. Bifurcation analysis performed with respect to TEBF1 values shows a single positive
steady state for system Eq (4), relative to the fully committed state, in correspondence of which
the expression of EBF1 and PAX5 are sustained at higher level and the FLT3 and IL-7R at
lower ones, S9 Fig (right panel).
Expanding the model by assembling together the latter two feedback loops (see S10 Fig left
panel) results in a reinforcement of the committed state, which does not provide the sought-
after switch-like behavior, as derived by means of bifurcation analysis of model Eq (5), see S10
Fig (right panel). Analysis of the network obtained by combining the ZNF521-EBF1 loop with
the EBF1/PAX5/FLT3/IL-7R one, see S11 Fig (left panel), does not appear to guarantee suffi-
cient conditions for bistable behavior (the corresponding model is given in Eq (6): bifurcation
analysis show the existence of positive steady-states relative to the committed lineage only, see
S11 Fig (right panels). Also the combination of the feedback loop EBF1-ZNF521 with the
EBF1/E2A/PAX5 one, see S12 Fig (left panel) and model Eq (7), does not yield bistability:
bifurcation diagrams show that the system converges toward committed state.
Finally, we examine the dynamics generated by the hypothesized novel interaction,
PAX5-ZNF521. Such interaction establishes a second feedback loop between EBF1 and
ZNF521 mediated by PAX5, as illustrated in S13 Fig (left panel). This feedback structure,
described by model Eq (8), is responsible for the irreversible commitment switch: bifurcation
diagrams in S13 Fig (right panel) show typical curves exhibiting bistable irreversible behavior
against variations in the transcriptional activation of EBF1.
Model assessment with respect to experimental observations
Similarly to other models of switch-like biological phenomena [11, 12], the proposed model is
not aimed at providing quantitatively exact predictions of molecular concentrations, but rather
to a system-level understanding of the mechanisms underlying the transitions between differ-
ent operative conditions. Therefore, an assessment of the model plausibility can be done by
means of a qualitative comparison of the in silico behavior with respect to the experimental bis-
table characteristics, rather than relying on some goodness-of-fit metrics. Thus, we compared
the model steady-states with gene expression profiling datasets, focusing on the qualitative
agreement between the model results and the gene profiling expressions (differentially gene
expression results are reported in Fig 2 and S1 Fig). To confirm the phenomenological plausi-
bility of the proposed model, we analyzed the results with respect to known molecular pheno-
types, characterized by particular expression programs. We explicitly assessed the states of the
attractors with gene expression profiles of differentiating multipotent progenitors toward B-
lymphocytes. Human CD34+/lin− and precursor B-cell subsets specific expression values were
taken from [20, 21]. Fig 5 reports a comparison between experimental expression data and the
model equilibrium points, highlighting only those factors whose expression varies by a signifi-
cant amount across the different cellular states, namely, EBF1, PAX5 and ZNF521, and the
markers FLT3 and CD19, expressed on the cell surface in the multipotent and committed
stage, respectively.
For instance, in correspondence to the multipotent stage, the proposed model properly cap-
tures a higher expression of the LMPP phase promoters FLT3 and ZNF521; at the same time,
the expression of the promoters of the lineage-restriction activity, EBF1, PAX5 and the surface
B-precursor marker, CD19, is suppressed. In the B-lymphoid progenitors lineage, instead, the
main fate B-cell development determinants EBF1, PAX5 and CD19 are strongly expressed in
both experimental data and computational predictions, whereas FLT3 as ZNF521 are strongly
repressed. These results suggest that the proposed commitment-switch model, derived by a
combination of experimentally validated interactions and modeling hypotheses, is capable of
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reproducing the bistable behavior of the experimental system, in correspondence of the point
in the parameter space defined by the solution proposed in S1 Table. This is not sufficient to
determine the model plausibility: due to the significant inter-cellular variability of biomolecular
circuits, a model can only be considered plausible if it is robust, i.e., the desired behavior is
reproduced not only for a particular choice of the parameters, but over a non-trivial subset of
the parameter-space [45–47].
Parametric sensitivity analysis showed that the bistable behavior of the proposed model is
robust with respect to variations of the parameters involved in the dynamics of ZNF521 and
EBF1. We have examined the range of parameter values in which bistable behavior is pre-
served, see S2 Table. In particular, the parameter b4, that expresses the strength of the inhibi-
tion of PAX5 on ZNF521 in the nonlinear ODE model Eqs (1a)–(1j), can assume a wide range
of values, log2 fold change value: [-0.524; 2.944], computed as the log2 ratio between the mini-
mum and maximum admissible value, respectively, for which the system is bistable and the
parameter used in the model, S1 Table. Furthermore, we have been able to identify domains of
variation of the parameters involved in the dynamics of IL-7R and E2A, which are character-
ized by bistable dynamics. This is in agreement with the fact that these factors are known to
play a crucial role in B lymphopoiesis, as reported in the S1 Text. The parametric robustness of
the proposed model supports its plausibility, suggesting that the qualitative response does not
depend on the particular choice of the parameters, but is rather a structural feature emerging
from the topology of the interaction network and the kinetics of these interactions.
Reprogramming strategies of B-lymphoid LRPs into multipotent
progenitors
Directly increasing the EBF1 transcriptional activity, TEBF1, the EBF1 levels are sufficient to
induce PAX5 expression, which, in turn, decreases ZNF521 and FLT3 levels, see Fig 4. Conse-
quently, TCF3, EBF1 and PAX5 are activated, leading to lymphoid-LRP commitment (specified
by expression of the surface marker CD19). The dynamics of these master regulators yield two
stable regimes, corresponding to the two lymphoid differentiation stages. In principle, by mod-
ulating the external factors that regulate the expression of EBF1 and ZNF521, it is possible to
revert the cell differentiation state from LRP to LMPP. To this aim, we need a strategy to make
the system retrace back the classical S-shaped curves displayed in Fig 4. Since the bifurcations
are driven by the master regulators EBF1, PAX5 and ZNF521, we have to act on these knobs to
try to reprogram the cell fate.
Fig 5. Comparison between experimental expression profiling and computed attractors. Each condition, for both experimental and model results, is
normalized with respect to the given maximum value. It is possible to note a good agreement, in terms of bistable behavior, between the model prediction, the
measured expression of the key factors involved in the commitment switch and the markers of the multipotent and the committed stage (FLT3 and CD19),
respectively. Blue bars correspond to the LMPP stage, green bars to the LRP in the pro-B phase.
doi:10.1371/journal.pone.0132208.g005
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In some cases it is sufficient to modify the expression of a single transcription factor within
a gene regulatory network to reprogram the cell fate [48]. An important question is whether
the mutually inhibitory feedback from EBF1 to ZNF521, and the feedback from PAX5 to FLT3
are essential to provide reinforcement of the commitment decision, and, more importantly,
under which conditions the network can be modified to reverse the commitment. According to
our model, the system can be reprogrammed from a state of lineage-restricted commitment by
acting on the sole expression of ZNF521: this is evidenced by the bifurcation diagrams reported
in Fig 6, showing that an increase in the expression of ZNF521 transforms the irreversible
switch into a reversible one. Under unperturbed conditions, the irreversibility of the switch is
guaranteed by the repressing action of PAX5 on ZNF521, which is directly influenced by the
expression level of EBF1 but not by that of ZNF521. Therefore, to make the cell return to the
preceding differentiation step, it is necessary to counteract this repression action by means of
an exogenous transcriptional activation of ZNF521. As a consequence, the cell recovers the
multipotent characteristics as self-renewal and differentiation into different lineages proceed-
ing from a multipotent stage.
Discussion
Unveiling the mechanisms underpinning multipotent cell lineage commitment is one of the
main goals of systems biology. The heterogeneity of multipotent and progenitor cells produces
sub-populations that express slightly different properties and propensities to commit towards
the various lineages.
Fig 6. EBF1-dependence of the B-cell development bifurcation diagramw.r.t the ZNF521
transcriptional activation. (a) EBF1 versus external factor TEBF1 with no activation of ZNF521, TZNF521 = 0.
Overexpression of EBF1 is sufficient to switch the system from the LMPP state (low EBF1) to the pro-B (high
EBF1) state, as indicated by the arrows. (b) EBF1 versus external factor TEBF1 with transcriptional activation
of ZNF521, TZNF521 = 0.12. A couple of limit points (LPs) defines a region of bistability for the proposed
network. In this case, transcriptional activation of ZNF521 may convert the system from an irreversible to a
reversible bistable switch. (c) EBF1 versus external factor TEBF1 with transcriptional activation of ZNF521,
TZNF521 = 0.3. Consistently, higher values of transcriptional activation of ZNF521 entailing a sharp delay in B-
cell development, showing a more ultrasensitive response to higher values of TEBF1.
doi:10.1371/journal.pone.0132208.g006
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In hematopoiesis, cell fate mechanisms at the level of multipotent progenitors commitment
toward B-lymphoid progenitors are still only partially elucidated and, to our knowledge, no model
has so far been developed to describe the regulation of this differentiation stage. We have
described these mechanisms by means of a phenomenological mathematical model, to quantita-
tively characterize the transcriptional dynamics regulating the commitment of multipotent lym-
phoid progenitors to lymphoid LRPs. The proposed model focuses on the role of the transcription
co-factor ZNF521, a stem cell-associated protein that has been implicated in the regulation of the
homeostasis of the immature compartment in a variety of normal and neoplastic tissues [17, 18,
34, 49–57]. In particular, previous work from our group suggested that ZNF521 can antagonize
B-cell development and contribute to maintain the multipotency of primitive lympho-myeloid
progenitors, by counteracting their EBF1-driven B-lymphoid commitment [18]. In the present
study, the different stages of lineage commitment and differentiation have been described mathe-
matically in terms of stable attractors in the state-space of the devised dynamical model.
It is important to remark that the main goal of our work is to propose a phenomenological
model useful for the comprehension of the regulatory mechanisms underlying some steps of B-
lymphoid cell differentiation; for this reason, the model is not intended as a tool for quantitative
prediction of gene expression but, rather, for describing the qualitative response of the system
during the various differentiation stages and for pinpointing the key molecular mechanisms
that enable the lineage commitment. Due to the lack of experimental evidences regarding the
nature of the molecular reactions, only heterodimeric pairwise interactions have been consid-
ered in the design of the model. Although the restriction to this class of models limits the gener-
ality of our approach, it has been deemed necessary to a) limit the arbitrariness that is inherent
in the process of deriving a model from a network of interactions, and to b) focus our study on
the discovery of novel putative molecular mechanisms responsible for the lineage commitment
switch. An alternative approach would have been to investigate whether the bistable behavior
might be explained by the introduction of high-order cooperative effects, for example in the
feedback loop EBF1-ZNF512. However, it is well known that by choosing a suitable complex
kinetics it easy to induce a bistable behavior, even in very simple reaction networks (even with
only two species). Therefore, the results obtained through this modeling approach would not
have been useful as a discriminating factor for guiding future biological experiments.
The main objective of this work is to identify novel putative transcriptional interactions that
mediate an irreversible switch-like commitment of multipotent progenitors toward the B-lym-
phoid lineage. ZNF521 has been shown to interact with multiple molecular partners, that are
likely to mediate its regulatory activities [17, 34, 49–52, 55]. Among these, the inhibition of
EBF1 appears to be of particular relevance in the maintenance of the homeostasis of the early
hematopoietic cell compartment by opposing the activity of ZNF521[18].
A first contribution of the work has consisted in the design of a mathematical model that
recapitulates the known regulatory interactions between the molecular factors involved in the
lineage commitment of B-lymphoid cells, including ZNF521. Subsequently, this nominal
model has been exploited to evaluate the plausibility of newly hypothesized interactions, not
yet experimentally validated. These putative interactions have been translated into different
extended models, which have been analyzed to establish their capability to exhibit the sought-
after switch-like behavior. Model assessment has also been performed by comparison between
the simulated expression profiles and experimental gene expression datasets, showing a good
qualitative agreement between the simulated and the experimentally observed behavior.
Model-based quantitative analysis has shown that the currently known experimentally vali-
dated interactions are not sufficient to explain the irreversible commitment dynamics; starting
from this finding. Among the various hypotheses that have been investigated, the most conceiv-
able resulted to be the existence of an inhibitory effect of PAX5 on the transcription of ZNF521.
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PAX5 encodes a transcriptional regulator that has been shown to enable the B-cell-specific
genetic program while repressing alternative ones [58]. Interestingly, Busslinger and colleagues
have identified Pax5 binding within the Zfp521 locus in pro B cells [59], although they have not
evidenced regulation of Zfp521 by Pax5. Direct repression of Zfp521, which is also highlighted in
our model as the consequence of a possible direct interaction, has been reported in adipocyte
progenitors by Kang et al. [34]. Considering that the expression of EBF1 precedes that of PAX5,
it can be hypothesized that the initial ZNF521 repression by EBF1 is sufficient to lower the
expression levels of the former, such that a further reduction of its expression in response to
PAX5 may be undetectable by the gene profiling method used. Endowing our model with the
PAX5 a ZNF521 interaction has resulted in the appearance of the commitment switch dynamics
associated to the changes in the expression level of EBF1, PAX5 and ZNF521.
Sensitivity analysis of the model parameters has allowed us to assess the robustness of the
commitment switch with respect to inter-cellular parametric variability, thus supporting the
plausibility of the proposed mathematical description of the regulatory interaction network.
Moreover, sensitivity analysis has supported the identification of the key interactions driving
the lineage commitment mechanism: the parameters involved in the dynamics of EBF1 and
ZNF521, that are a0, a2, . . ., a8, a10, . . ., a12, b0, b2, . . ., b4, exhibit a substantial range of varia-
tion in which switch like behavior is preserved; a quantitative evaluation of such ranges of vari-
ation is illustrated in S3 Fig and in S2 Table. The parameters f0, . . ., f3, j0, j1, which are involved
in the dynamics of IL-7R and E2A, can also determine a loss of the switch-like behavior if their
values fall outside certain intervals; S4 Fig and S2 Table report the detailed analysis performed
on this parameters and the bounds of the corresponding bistability intervals. Such analysis has
suggested that these factors are critical for transitions between the two solutions. Instead, the
remaining parameters, involved in the dynamics of GFI1, PU.1, IKAROS (only its basal expres-
sion has been considered) FLT3, CD19, PAX5 show unimodal behavior for single variation, i.e.
each parameter value is characterized by a single CD19 homeostatic level starting point, S5 Fig.
Under nominal conditions, the commitment mechanism has resulted to be irreversible, as
expected according to the experimental observations (see Fig 4). By exploiting the devised
model, we have been able to design a possible reprogramming strategy from the LRP to LMPP
stage, which may provide a valuable indication for future experimental investigations, (see Fig
6). The analyses conducted on our model suggest that a) increased transcription of ZNF521
transforms the characteristic response of the commitment switch from an irreversible to a
reversible form and b) the ZNF521-overxpressing cells may then be reverted to a multipotent
state by repressing the expression of EBF1. It is interesting to notice, in this regard, that Zfp521
is among the 36 HSC-associated genes that have been initially used by Riddell et al. [60] to
reprogram committed mouse hematopoietic cells to induced HSCs. Although in subsequent
experiments a more restricted cocktail of factors that did not include Zfp521 has proven suffi-
cient for this reprogramming, it will be of interest to test whether the combined overexpression
of ZNF521 and silencing of EBF1may indeed be effective in inducing the generation of multi-
potent progenitors from committed human B-lymphoid progenitors.
Dynamical models and the associated analysis methods provide effective tools for the com-
prehension of complex biological systems and for the in silico design of novel approaches to
control their evolution. The regulatory mechanisms underlying multipotent cells differentia-
tion represent a highly rewarding application field for such tools, as proven by previous analo-
gous works, e.g. [12, 15, 16]. While the necessary steps of wet-lab experimental validation
(such as the demonstration of the direct repression of ZNF521 by PAX5 or the consequences of
enforced expression of ZNF521 in B-lymphoid progenitors that are currently underway) can-
not be replaced by computational modeling and simulations, the presented results represent an
advancement towards the comprehension of some key steps of B lymphopoiesis and will
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hopefully prove to be helpful in streamlining future experimental activity to better elucidate
the hematopoietic regulatory mechanisms.
Materials and Methods
Determination of the transcriptional regulatory network
The first step in the generation of the proposed model consisted in the determination, based on
the literature, of the key factors involved in the commitment of B-lymphoid lineage, and how
these interact. The development of B lymphocytes from HSCs is organized as a multi-step pro-
gramming process, turning on B-cell specific genes and silencing the expression of others. The
commitment is initiated in correspondence of the LMPP stage, where the two transcription fac-
tors IKAROS and PU.1 start the early cellular specification [61, 62]. IKAROS and PU.1 can
directly regulate the expression of FLT3, which is a marker of the LMPP stage [24, 25]. Our
study also focused on the role of ZNF521 as an additional indicator of the multipotent develop-
mental stage. At a later stage, the commitment of the lymphoid progenitor to B-lymphoid
LRPs is essentially driven by three transcription factors: E2A, EBF1, and PAX5 [35]. This new
stage is identified by a high expression level of CD19 on the cell surface. In the S1 Text, we pro-
vide a detailed analysis of the relevant literature, reporting the most up-to-date and significant
experimental evidences concerning the LMPP to B-lymphoid LRP commitment mechanism.
Furthermore, this biological information is arranged into a synthetic formal description, repre-
sented by the interaction network depicted in Fig 1.
Mathematical models
Full Model. The gene regulatory network in Fig 1 has been translated into a mathematical
model consisting of a set of nonlinear ordinary differential equations. The network dynamics
have been modeled using simple expressions (e.g. quadratic and Michaelis-Menten-like mathe-
matical terms), similarly to what is done with other phenomenological models of transcrip-
tional networks, e.g. [12, 15]. Furthermore, for the sake of simplicity, we considered the
following interpretation: the two cytokine signaling cascades on FLT3/Ras and IL-7R/Jak/Stat
are described as direct interaction on the respective target. Hence, our model consists of only
transcription factors and their interactions in a genetic control network, involving the ZNF521.
We assume that the concentrations are in dimensionless units and the kinetic constants are in
units of s−1, and the Michaelis-Menten constants are dimensionless. The corresponding
dynamical equations gives the following
dxIKAROS
dt
¼ i0  m1xIKAROS ð1aÞ
dxGFI1
dt





¼ g0 þ g1xPU:1




¼ ðe0 þ e1xPU:1 þ e2xIKAROS þ e3xPU:1xIKAROSÞ
 1=ð1þ e1xPU:1 þ e2xIKAROS þ e3xPU:1xIKAROS þ e4xPAX5
þ e5xPU:1xPAX5 þ e6xIKAROSxPAX5Þ  m4xFLT3
ð1dÞ
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dxIL7R
dt
¼ f0 þ f1xFLT3 þ f2xPU:1 þ f3xFLT3xPU:1









¼ b0 þ b1TZNF521 þ b2xZNF521




¼ ða0 þ a1TEBF1 þ a2xEBF1 þ a3xPAX5 þ a5xIL7R
þ a6xEBF1xIL7R þ a7xPU:1 þ a8xPAX5xPU:1 þ a10xE2A
þ a11xE2AxEBF1 þ a12xE2AxIL7RÞ
 1=ð1þ a1TEBF1 þ a2xEBF1 þ a3xPAX5 þ a4xZNF521
þ a5xIL7R þ a6xEBF1xIL7R þ a7xPU:1 þ a8xPAX5xPU:1
þ a9xPU:1xZNF521 þ a10xE2A þ a11xE2AxEBF1




¼ c0 þ c1xEBF1 þ c2xE2A þ c3xEBF1xE2A




¼ d0 þ d1xPAX5
1þ d1xPAX5
 m10xCD19 ð1jÞ
where xIKAROS, xGFI1, xPU.1, xFKT3, xIL-7R, xE2A, xZNF521, xEBF1, xPAX5, and xCD19 stand for the
corresponding expression levels, the parameters a0, b0, c0, d0, e0, f0, g0, h0, i0 and j0 represent the
basal production rate of each protein and the μi with i = 1, . . ., 10, deﬁne the degradation rates.
Each protein is transcribed by RNA polymerase when it is bound either by one or more tran-
scription factors. For each transcription factor involved in the model, we assume the level of
protein approximately proportional to the mRNA levels. In Eqs (1h) and (1g) we assumed by
TEBF1 and TZNF521 the environmental factors activating the transcriptional activity of EBF1 and
ZNF521, respectively, in order to analyze the effects on early B lymphopoiesis lineage commit-
ment, promoting in turn the activation of one of these key regulators.
EBF1/ZNF521 feedback. The dynamical equations corresponding to the simple feedback
between EBF1 and ZNF521, reported in S7 Fig, assume the form:
dxEBF1
dt
¼ a0 þ a1TEBF1 þ a2xEBF1




¼ b0 þ b1TZNF521 þ b2xZNF521
1þ b1TZNF521 þ b2xZNF521 þ b3xZNF521xEBF1
 m7xEBF1 ð2bÞ
Computational Modeling of B-Lymphocyte Lineage Commitment
PLOS ONE | DOI:10.1371/journal.pone.0132208 July 13, 2015 14 / 23
EBF1/E2A/PAX5 feedback. The dynamical equations corresponding to the EBF1/E2A/
PAX5 positive feedback, reported in S8 Fig, are given by:
dxEBF1
dt
¼ a0 þ a1TEBF1 þ a2xEBF1 þ a10xE2A þ a11xE2AxEBF1









¼ c0 þ c1xEBF1 þ c2xE2A þ c3xEBF1xE2A
1þ c1xEBF1 þ c2xE2A þ c3xEBF1xE2A
 m9xPAX5 ð3cÞ
EBF1/PAX5/FLT3/IL-7R feedback. The dynamical equations corresponding to the feed-
back involving EBF1, PAX5, FLT3 and IL-7R, reported in S9 Fig, are expressed as follows:
dxEBF1
dt
¼ a0 þ a1TEBF1 þ a2xEBF1 þ a3xPAX5 þ a5xIL7R þ a6xEBF1xIL7R















¼ f0 þ f1xFLT3
1þ f1xFLT3
 m5xIL7R ð4dÞ
EBF1/E2A/PAX5/FLT3/IL-7R feedback. The dynamical equations corresponding to the
feedback involving EBF1, E2A, PAX5, FLT3 and IL-7R, reported in S10 Fig, are given by:
dxEBF1
dt
¼ ða0 þ a1TEBF1 þ a2xEBF1 þ a3xPAX5 þ a5xIL7R
þ a6xEBF1xIL7R þ a10xE2A þ a11xE2AxEBF1 þ a12xE2AxIL7RÞ
 1=ð1þ a1TEBF1 þ a2xEBF1 þ a3xPAX5 þ a5xIL7R










¼ c0 þ c1xEBF1 þ c2xE2A þ c3xEBF1xE2A
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dxIL7R
dt
¼ f0 þ f1xFLT3
1þ f1xFLT3
 m5xIL7R ð5eÞ
ZNF521/EBF1/PAX5/FLT3/IL-7R feedback. The dynamical equations corresponding to




¼ ða0 þ a1TEBF1 þ a2xEBF1 þ a3xPAX5
þ a5xIL7R þ a6xEBF1xIL7RÞ
 ð1þ a1TEBF1 þ a2xEBF1 þ a3xPAX5 þ a4xEBF1xZNF521




¼ b0 þ b1TZNF521 þ b2xZNF521














¼ f0 þ f1xFLT3
1þ f1xFLT3
 m5xIL7R ð6eÞ
ZNF521/EBF1/E2A/PAX5 feedback. The dynamical equations corresponding to the
module constituted by ZNF521/EBF1/E2A/PAX5, reported in S12 Fig, assume the form:
dxEBF1
dt
¼ ða0 þ a1TEBF1 þ a2xEBF1 þ a3xPAX5
þ a10xE2A þ a11xEBF1xE2AÞ
 ð1þ a1TEBF1 þ a2xEBF1 þ a3xPAX5 þ a4xEBF1xZNF521




¼ b0 þ b1TZNF521 þ b2xZNF521









¼ c0 þ c1xEBF1 þ c2xE2A þ c3xEBF1xE2A
1þ c1xEBF1 þ c2xE2A þ c3xEBF1xE2A
 m9xPAX5 ð7dÞ
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EBF1/PAX5/ZNF521 feedback. The dynamical equations corresponding to the EBF1/
PAX5/ZNF521 feedback, reported in S13 Fig, assume the form:
dxEBF1
dt
¼ a0 þ a1TEBF1 þ a2xEBF1 þ a3xPAX5





¼ b0 þ b1TZNF521 þ b2xZNF521




¼ c0 þ c1xEBF1
1þ c1xEBF1
 m9xPAX5 ð8cÞ
Numerical simulations and bifurcation analysis have been performed by using MATLAB and
the MATCONT continuation package [63], respectively. In order to get a biologically plausible
model, we tuned the values of the model parameters such that the simulated response of the
model matched the qualitative behavior of the experimental system, according to the experi-
mental data reported in a set of microarray gene experiments. Given a certain network topol-
ogy, along with a tentative model of its dynamics and admissible intervals of its parameters, the
Bifurcation Discovery Tool (BDT) allows the computation of parameter set values that give
rise to bifurcations [64]. The parameter space is explored by means of a genetic algorithm,
seeking Hopf bifurcations, turning points and bistable switches. In particular, starting from an
ODE-based reaction network, BDT allows an user to choose the parameters to be searched, the
admissible parameter ranges, and the nature of the bifurcation to be sought. As a result, the
tool will return the parameter values for which the sought-after behavior is observed. We have
identified a set of parameter values that correspond to a bistable behavior of the network and
to a system response that is in agreement with experimental measurements.
Microarray expression profiling
We considered gene expression given as supplementary data in [20, 21]. In the latter works, the
authors treated the development of precursor B-cells from hemopoietic stem cells toward dif-
ferentiation through a number of stages in the bone marrow before their migration to the
periphery as naive mature B lymphocytes. (ArrayExpress Database, accession no. E-MEXP-
384). B-cells progenitors were obtained from bone marrow samples of healthy children (age
3–16). Lineage-depleted (lin−) human cells enriched for expressing CD34 (CD34+ cells) were
obtained from umbilical cord blood, since it is impossible to obtain enough CD34+/lin− cells
from bone marrow samples. In general, lin− cells identify all the stem and progenitor cells for
which mature cell lineage markers expression is undetectable. We have performed gene expres-
sion profiling using Affymetrix Expression Console, applying a robust multi-array normaliza-
tion, and Transcriptome Analysis Console for differential expression analysis. Expression
Console and TAC Softwares can be freely downloaded from the Affymetrix website.
Supporting Information
S1 Text. Supporting Text.
(PDF)
S1 Fig. Volcano plot showing gene level differential expression between the two conditions
CD34+/lin− and pro-B vs. significance value. All the points having a fold change (linear)
greater than 2 and p-value< 0,05 indicate points-of-interest characterized by both large-
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magnitude fold-changes as well as high statistical significance (-log10 of p-value). All that
points having a fold change (linear) less than 2 and p-value greater than 0,05 are shown in
gray. Red: up in CD34+/lin− vs pro-B; green: down in CD34+/lin− vs pro-B. Highlighted are
shown the factors involved in the proposed model confirming a well agreement between exper-
imental and computed results.
(EPS)
S2 Fig. Time profile concentrations of FLT3, ZNF521, EBF1, PAX5 and CD19 for the two
cellular stages, indicating the final steady state values. (a)When the ZNF521 is activated, the
LMPPs specified genes are highly expressed arresting the development of B cells. Differently,
(b) when no factor stimulates the expression of ZNF521, the system is driven towards the lym-
phoid lineage fate, resulting in a higher expression of the B-lymphoid LRP specified genes.
(EPS)
S3 Fig. CD19 bifurcation analysis with respect to the parameters involved in EBF1 and
ZNF521 transcriptional dynamics. The parameters associated to EBF1 transcription, a0, a2,
. . ., a8, a10, . . ., a12, and all the parameters involved in ZNF521 transcription, b0, b2, . . ., b4
exhibit an interval where bistable solutions can be found.
(EPS)
S4 Fig. CD19 bifurcation analysis with respect to the parameters involved in IL-7R, PU.1,
IKAROS and E2A transcriptional dynamics. The parameters associated to IL-7R transcrip-
tion, f0, . . ., f3 and to E2A transcription, j0, j1 exhibit an interval where bistable solutions can be
found. Individual variations of the kinetic parameters describing the PU.1 dynamics, g0, . . ., g2,
the GFI1 dynamics, h0, h1 and the basal expression of IKAROS, i0, instead, do not give rise to
bistability.
(EPS)
S5 Fig. CD19 bifurcation analysis with respect to the parameters involved in PAX5, CD19
and FLT3 transcriptional dynamics. The parameters associated to PAX5 transcription, c0, . . .,
c3, to CD19 transcription d0, d1 and all the parameters involved in FLT3 transcription, e1, . . .,
e6 (with the only exception of its basal expression, e0), do not give rise to bistability.
(EPS)
S6 Fig. Comparison of the proposed model with different hypothetical configurations.
Bifurcation study proves the crucial role of the inhibition of PAX5 on ZNF521 expression to
admit the existence of commiment switching between LMPP and pro-B stages in B-lympho-
cyte development. Starting numerical continuation from the LMPP stage, let us impose the
conditions related to the case of reversible commitment switch, for TZNF521 = 0.12.Model A.
As already seen, ZNF521 inhibition through PAX5 generates a bistable commitment switch
between LMPPs (lower values of CD19 expression) and LRP cells (greater values of CD19
expression).Model B. Removing ZNF521 inhibition through PAX5, the effects of inhibition of
ZNF521 through the factor E2A have been considered. In this case, the system is characterized
by a single CD19 expression level, preventing the occurrence of switching behavior.Model C.
Removing ZNF521 inhibition through PAX5, the effects of ZNF521 repression through
IKAROS have been considered. Also in this case, CD19 reaches a single expression level.
(EPS)
S7 Fig. Dynamical analysis of the EBF1/ZNF521 feedback module. The EBF1-ZNF521
mutual inhibition, with autoregulatory interactions; the environmental factors, which promote
the transcriptional activity of EBF1 and ZNF521 are indicated as TEBF1 and TZNF521, respec-
tively. The intersection among the nullclines dZNF521/dt = 0 and dEBF1/dt = 0, with
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parameters given by S1 Table, identifies a single stable point (SS) corresponding to the LMPP
point (upper right panel). Bifurcation analysis performed promoting the transcriptional activ-
ity of EBF1 shows the existence of a single inaccessible turning point (LP), for negative values
of TEBF1 (lower right panels). Solid line denotes stable steady-states, dashed line denotes unsta-
ble ones.
(EPS)
S8 Fig. Dynamical analysis of the EBF1/E2A/PAX5 feedback module. The positive feedback
loop constituted by EBF1, E2A and PAX5, with autoregulatory loop and the environmental fac-
tor, TEBF1, acting on EBF1 transcription. Bifurcation analysis shows the expression levels of the
corresponding factor as functions of TEBF1. It is possible to note that this feedback sustains the
committed state, admitting only one stable positive point (right panels).
(EPS)
S9 Fig. Dynamical analysis of the EBF1/PAX5/FLT3/IL-7R feedback module. As suggested
by experimental findings, EBF1, PAX5, FLT3 and IL-7R form a negative loop (left panel).
Bifurcation analysis performed with respect to TEBF1 values shows that this feedback admits a
single positive steady state, relative to the committed state, in correspondence of which the
expression of EBF1 and PAX5 are sustained at higher level and the FLT3 and IL-7R at lower
ones (right panels). Solid line denotes stable steady-states, dashed line denotes unstable ones.
(EPS)
S10 Fig. Dynamical analysis of the EBF1/E2A/PAX5/FLT3/IL-7R feedback module. The
feedback loop comprising the positive loop involving EBF1, E2A and PAX5 and the negative
one constituted by EBF1, PAX5, FLT3 and IL-7R (left panel). Bifurcation diagrams show the
expression levels of the involved factors as functions of TEBF1. It is possible to observe a rein-
forcement of the committed state, which does not provide the sought-after switch-like behavior
(right panels).
(EPS)
S11 Fig. Dynamical analysis of the ZNF521/EBF1/PAX5/FLT3/IL-7R feedback module.
The module constituted by the mutual inhibition between ZNF521 and EBF1, with autoregula-
tory loops, and the negative feedback formed by EBF1/PAX5/FLT3/IL-7R (left panel), does not
appear to be sufficient to bistability behavior. Bifurcation analysis performed versus TEBF1
show the existence of only positive steady-states relative to the committed lineage (right pan-
els). Solid line denotes stable steady-states, dashed line denotes unstable ones.
(EPS)
S12 Fig. Dynamical analysis of the ZNF521/EBF1/PAX5/E2A feedback module. The mod-
ule constituted by the mutual inhibition between ZNF521 and EBF1, with autoregulatory
loops, and the positive feedback loop that sustain the committed state, EBF1/E2A/PAX5 (left
panel), are unable to capture the required switch-like behavior. Observing the bifurcation dia-
grams (right panels) for consistent values of TEBF1 the system converges to the committed
state. Solid line denotes stable steady-states, dashed line denotes unstable ones.
(EPS)
S13 Fig. Dynamical analysis of the EBF1/PAX5/ZNF521 feedback module. The EBF1/
ZNF521 mutual inhibition, with autoregulatory loops, is enriched by a further interaction
through the key factor PAX5. Observing the bifurcation diagrams (right panels) with respect to
the TEBF1 values, this feedback induces irreversible bistable behavior. Solid line denotes stable
steady-states, dashed line denotes unstable ones.
(EPS)
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S1 Table. Parameter values used in the dynamical equations. Set of parameter values in cor-
respondence of which the main model exhibits a classic bistable behavior.
(PDF)
S2 Table. Parameter sensitivity coefficients for bistability. The parameter sensitivity for bist-
ability is defined as the log2 fold change of the ratio between the max (min) parameter value
for which the system is bistable and the parameter used in the model, S1 Table.
(PDF)
S3 Table. Parameter values used in the model B and C bifurcation studies. Parameters val-
ues used as different configurations of the original transcriptional regulatory network, consid-
ering reasonable regulatory gene hypotheses.
(PDF)
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